Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 612 results found. Search for [ AstraZeneca Pharma ]

Results 1 to 21 of 612
PTI
May 12, 2021
The trial will take place in 525 subjects at various sites, including AIIMS, Delhi, AIIMS, Patna and Meditrina Institute of Medical Sciences, Nagpur


BusinessToday.In
May 11, 2021
AstraZeneca remuneration committee said that it undertook in-depth consultation with its largest shareholders regarding the pay policy. It also acknowledged the fact that a lot of investors did not favour the same


Reuters
May 11, 2021
PHE said the study was the first on protection against mortality from the AstraZeneca vaccine based on data from a real world setting


Reuters
May 10, 2021
Based on these delivery contracts, the firm said it expects about 12.4 billion euros ($15.1 billion) in revenues from the product this year, including sales, milestone payments from partners and a share of gross profit in the partners' territories


Reuters
May 10, 2021
We did not renew the order after June. We'll see what happens, European Internal Market Commissioner Thierry Breton told France Inter radio. He did not rule out a potential renewal at a later stage


PTI
May 8, 2021
While WHO has listed the Pfizer/BioNTech, Astrazeneca-SK Bio, Serum Institute of India, Janssen vaccines for emergency use, the Chinese vaccine got delayed recognition due to data related issues


PTI
May 4, 2021
COVAX urgently needs 20 million doses during the second quarter of 2021 to cover interruptions in supply triggered by increased demands for vaccines in India where COVAX's main supplier of the AstraZeneca product is based, according to WHO


PTI
May 1, 2021
Gen Shavendra Silva, chief of COVID prevention operations, said supply is being delayed from the Serum Institute of India in the wake of the current COVID crisis in the country


BusinessToday.In
May 1, 2021
The pharma giant, which manufactures the AstraZeneca COVID-19 vaccine is going to make a formal announcement in the next few days


BusinessToday.In
April 30, 2021
The US will also dispatch 20,000 courses of Remdesivir by early next week besides sending Milipore filters from its own stockpiles that will enable the production of 18 million AstraZeneca jabs in India at the earliest


PTI
April 28, 2021
Developed by Bharat Biotech in partnership with National Institute of Virology and the Indian Council of Medical Research, Covaxin was approved for emergency use on January 3


PTI
April 28, 2021
Allow India to develop that vaccine, and this is good in your own long-term interests. It's good for the United States and our interests with the role with India and the rest of the world, Ro Khanna told the media


PTI
April 25, 2021
Indian-American Congressman Raja Krishnamoorthi urged the Biden administration to release doses of the AstraZeneca vaccine to countries currently experiencing the deadly surge in COVID-19 cases.


PTI
April 24, 2021
Odds of new SARS-CoV-2 infection were reduced 65 per cent in those 21 days since first vaccination with no second dose versus unvaccinated individuals without evidence of prior infection, the Oxford University study noted


Reuters
April 24, 2021
We are no longer recommending a pause in the use of this vaccine, CDC Director Rochelle Walensky told a news briefing


Reuters
April 23, 2021
The vaccines from the U.S. drugmaker and its German partner BioNTech would be delivered over 2021-2023, Commission President Ursula von der Leyen said during a visit to Pfizer's vaccine plant in Puurs, Belgium


Reuters
April 23, 2021
Public forecasts by its only two vaccine producers show their total monthly output of 70-80 million doses will increase only in two months or more, though the number of people eligible for vaccines will double to an estimated 800 million from May 1


BusinessToday.In
April 22, 2021
Shares of Panacea Biotech were locked in the 10 per cent upper circuit for the second straight day, at Rs 323.70, hitting an over 12-year high on the BSE on Thursday


BusinessToday.In
April 20, 2021
The Centre on Monday announced that people above the age of 18 will be eligible for the COVID-19 vaccine from May 1. Under the revised policy, vaccine manufacturers will be allowed to release 50 per cent of doses to the open market


PTI
April 20, 2021
The company has sought an early meeting of the subject expert committee on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) to take a decision on its application


PAGES 1 OF 31  12345